drugset / Trial / NCT01536392
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to compare granisetron (when given through a patch) to ondansetron (when taken by mouth) for reducing nausea and vomiting in women with cervical, endometrial, or vaginal cancer having chemoradiation. Granisetron and ondansetron are designed to help reduce nausea and vomiting.
Timeline
- Start
- 2012-03
- Primary completion
- 2019-10-03
- Completion
- 2019-10-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granisetron | Other / unclassified | 34.3 mg | Other |
| Subject | Ondansetron | Other / unclassified | 8 mg | Oral |